Can we afford to ignore missing data in cost-effectiveness analyses?

被引:17
作者
Marshall, Andrea [1 ]
Billingham, Lucinda J. [2 ]
Bryan, Stirling [3 ]
机构
[1] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[2] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[3] Univ Birmingham, Hlth Econ Facil, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
MULTIPLE IMPUTATION; ECONOMIC SUBMISSIONS; RANDOMIZED-TRIAL; VALUES; GUIDELINES; SURVIVAL; PROGRAM; CANCER; UPDATE; CARE;
D O I
10.1007/s10198-008-0129-y
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 29 条
  • [1] Estimating medical costs with censored data
    Bang, H
    Tsiatis, AA
    [J]. BIOMETRIKA, 2000, 87 (02) : 329 - 343
  • [2] Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer
    Billingham, LJ
    Bathers, S
    Burton, A
    Bryan, S
    Cullen, MH
    [J]. LUNG CANCER, 2002, 37 (02) : 219 - 225
  • [3] Missing .... presumed at random: cost-analysis of incomplete data
    Briggs, A
    Clark, T
    Wolstenholme, J
    Clarke, P
    [J]. HEALTH ECONOMICS, 2003, 12 (05) : 377 - 392
  • [4] Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
    Burton, A
    Altman, DG
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (01) : 4 - 8
  • [5] Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
    Burton, Andrea
    Billingham, Lucinda Jane
    Bryan, Stirling
    [J]. CLINICAL TRIALS, 2007, 4 (02) : 154 - 161
  • [6] Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
    Cullen, MH
    Billingham, LJ
    Woodroffe, CM
    Chetiyawardana, AD
    Gower, NH
    Joshi, R
    Ferry, DR
    Rudd, RM
    Spiro, SG
    Cook, JE
    Trask, C
    Bessell, E
    Connolly, CK
    Tobias, J
    Souhami, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3188 - 3194
  • [7] Guidelines for authors and peer reviewers of economic submissions to the BMJ
    Drummond, MF
    Jefferson, TO
    [J]. BRITISH MEDICAL JOURNAL, 1996, 313 (7052) : 275 - 283
  • [8] Harrell F. E., 2001, Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis, V608
  • [9] A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment. for heroin dependence in a primary care setting
    Harris, AH
    Gospodarevskaya, E
    Ritter, AJ
    [J]. PHARMACOECONOMICS, 2005, 23 (01) : 77 - 91
  • [10] Evaluating the BMJ guidelines for economic submissions -: Prospective audit of economic submissions to BMJ and The Lancet
    Jefferson, T
    Smith, R
    Yee, Y
    Drummond, M
    Pratt, M
    Gale, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (03): : 275 - 277